The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials
- 31 January 1997
- journal article
- Published by Elsevier
- Vol. 42 (1) , 39-48
- https://doi.org/10.1016/s0165-0327(96)00094-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctorsActa Psychiatrica Scandinavica, 1996
- Moclobemide and Tricyclic Antidepressants in Severe DepressionJournal of Clinical Psychopharmacology, 1995
- Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placeboJournal of Affective Disorders, 1995
- Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1993
- Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depressionActa Psychiatrica Scandinavica, 1991
- British Association for Psychopharmacology Max Hamilton Memorial Lecture Quantitative estimates of drug effects in psychopharmacology: what we measure and what we do notJournal of Psychopharmacology, 1990
- The use of rating scales exemplified by a comparison of the Hamilton and the Bech‐Rafaelsen Melancholia ScaleActa Psychiatrica Scandinavica, 1980
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A Theory and Procedure of Scale Analysis.Contemporary Sociology: A Journal of Reviews, 1973
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960